chr7-149266375-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001195220.2(ZNF783):c.65C>T(p.Ser22Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000025 in 1,597,722 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001195220.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF783 | ENST00000434415.6 | c.65C>T | p.Ser22Leu | missense_variant | 2/6 | 5 | NM_001195220.2 | ENSP00000410890.1 | ||
ZNF783 | ENST00000378052.5 | n.65C>T | non_coding_transcript_exon_variant | 2/14 | 2 | ENSP00000367291.1 | ||||
ZNF783 | ENST00000476295.5 | n.65C>T | non_coding_transcript_exon_variant | 2/11 | 2 | ENSP00000418666.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152066Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000170 AC: 4AN: 235376Hom.: 0 AF XY: 0.0000312 AC XY: 4AN XY: 128320
GnomAD4 exome AF: 0.0000263 AC: 38AN: 1445656Hom.: 1 Cov.: 31 AF XY: 0.0000292 AC XY: 21AN XY: 719410
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74266
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2024 | The c.65C>T (p.S22L) alteration is located in exon 2 (coding exon 2) of the ZNF783 gene. This alteration results from a C to T substitution at nucleotide position 65, causing the serine (S) at amino acid position 22 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at